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Abstract 
Background: 
Cardiovascular patients are likely to have an impaired health-related quality of life (HRQoL) due to 
functional and psycho-social limitations. The main objective of this study was to assess the distribution of 
HRQoL scores in coronary heart disease (CHD) patients across 22 European countries and to identify 
factors associated with the variation between patients. 
Methods: 
Data from the EUROASPIRE III survey (European Action on Secondary and Primary Prevention by 
Intervention to Reduce Events), on 8734 patients, were used. Patients with a diagnosis of CHD (coronary 
artery bypass graft (CABG), percutaneous coronary intervention (PCI), acute myocardial infarction (AMI) 
or myocardial ischaemia) were interviewed and examined at least 6 months after their acute coronary 
event. Quality of life of each patient was measured using 2 standardized questionnaires: the EuroQoL-5D 
(EQ-5D) and the 12-item short form health survey (SF-12v2). 
 
Results: 
HRQoL values differed significantly across countries. Lower HRQoL estimates were found in women, 
older patients, less educated, patients with myocardial infarction or ischaemia as recruiting diagnosis, 
patients with a history of stroke and patients who suffered from a recurring CHD event. In addition, 
HRQoL was significantly associated with current smoking, central obesity, lack of exercise and 
inappropriate HbA1c control in patients with diabetes. Furthermore the number of risk factors is 
inversely associated with HRQoL. 
 
Conclusion: 
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Overall, a large heterogeneity was observed in HRQoL values between countries and patient groups. 
There seems to be a significant association between quality of life and patient characteristics with 
lifestyle risk factors as important determinants of HRQoL.  
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Introduction 
Cardiovascular disease (CVD) remains the most common cause of disease burden in Europe, with 
coronary heart disease (CHD) being the single most important cause of death(1). Conventional treatment 
focuses mainly on functional outcomes, survival and extending life. However, morbidity and mortality 
rates are incomplete measures of outcome, since they do not reflect all aspects of health. Many patients 
consider the quality of the additional life years gained equally important as the length of life. Indeed, the 
goal of today’s medicine should be to increase both patients’ quantity and quality of life(2). In response, 
assessment of health-related quality of life (HRQoL) has been increasingly integrated in daily clinical 
practice. HRQoL is a subjective measure of overall well-being and reflects how a disease and its 
symptoms are perceived by a patient. Although there is no universal agreement on what constitutes 
HRQoL, current assessment focuses on the domains of social functioning, physical functioning and 
psychological functioning(3).  
CHD patients are known to have an impaired HRQoL(4). Recent studies have shown a significant 
influence of HRQoL on long-term outcomes. Poor HRQoL has been shown to predict morbidity and 
mortality in patients with CHD, even when controlling for standard risk factors(5-7).  
The aim of our study was to examine the relationship between the cardiovascular profile of coronary 
patients and their HRQoL. Data were derived from the EUROASPIRE III (European Action on Secondary 
and Primary Prevention by Intervention to Reduce Events) survey wherein two commonly used 
instruments were employed to assess patient’s HRQoL: the EQ-5D (EuroQol-5D) and the SF-12v2 (12-
item Short-Form Health Survey).  
Methods 
Study population and data collection 
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The details of the EUROASPIRE III study have been reported elsewhere(8). In brief, EUROASPIRE III, 
performed in 2006-07 in patients with established CHD, was a cross-sectional study to determine 
whether the European recommendations on CVD prevention were being followed in everyday clinical 
practice. Patients aged between 18 and 80 years, hospitalized for coronary artery bypass graft (CABG), 
percutaneous coronary intervention (PCI), acute myocardial infarction (AMI) or myocardial ischaemia, 
hereafter referred to as the recruiting diagnosis, were retrospectively identified from diagnostic 
registers, hospital discharge lists or other sources at 76 different hospital centres across 22 European 
countries: Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Finland, France, Germany, Greece, 
Hungary, Ireland, Italy, Latvia, Lithuania, Poland, Romania, Russian federation, Slovenia, Spain, The 
Netherlands, Turkey, and the United Kingdom (UK). Data collection was conducted by trained research 
staff using standardized methods and instruments. In total, 8,966 patients (participation rate=73%) were 
interviewed and examined at least 6 months and not later than 3 years after their initial hospital 
admission (mean=1.24 years). Informed consent was obtained from each patient and the study protocol 
conforms to the ethical guidelines of the 1975 Declaration of Helsinki (9). 
Patient characteristics and risk factors assessed 
The interview contained questions on personal and demographic details; medical and in particularly 
cardiovascular history (i.e. having a history of stroke or suffering from a recurrent coronary event 
between the recruiting diagnosis and the moment of interview); reported lifestyle and risk factor 
management related to smoking, exercise (regular exercise defined as 20-60 min, 3-5 x/week), blood 
pressure, lipids, glucose and medication. In addition, height, weight and waist circumference were measured 
in light indoor clothes without shoes, as well as blood pressure, heart rate and breath carbon monoxide. 
Venous blood was tested for serum total cholesterol, HDL-cholesterol, triglycerides, plasma glucose and 
HbA1c, the latter two were only measured in patient with self-reported diabetes(8). LDL was calculated 
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according to the Friedewald formula. The risk factor targets used, were based on the European guidelines on 
cardiovascular prevention(10). A raised blood pressure was defined as systolic blood pressure 
(SBP)/diastolic blood pressure (DBP) ≥ 140/90 mmHg (≥ 130/80 mmHg in patients with diabetes). A 
Raised total cholesterol was defined as total cholesterol ≥ 4.5 mmol/L. Raised LDL-cholesterol (LDL-C) 
was defined as LDL-C ≥ 2.5 mmol/L and Low HDL-cholesterol (HDL-C) was defined as HDL-C <1/1.2 
mmol/L for men/women. Raised fasting glucose was defined as fasting glucose ≥ 6.1 mmol/L among 
patients with self-reported diabetes and raised HbA1c as HbA1c ≥ 6.5% among patients with self-
reported diabetes. Low physical activity was defined as less than 20 min moderate physical activity, three 
times a week. Central obesity was defined as waist circumference > 102/88 cm (men/women). 
 
Health-related Quality of life assessment 
In order to assess patients’ HRQoL, they were asked to fill out 2 self-administered questionnaires: EQ-5D 
and SF-12v2. In each country, questionnaires were administered in the official language. Validity of these 
scales has been reported previously(11).  
The EQ-5D is an easy to complete brief instrument that contains a self classifier (EQ-5Dindex) covering 5 
dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression) and a visual 
analogue scale (EQ-VAS). In the current analyses only the EQ-VAS was included. The EQ-VAS is a vertical 
scale, ranging from 0 (worst imaginable) to 100 (best imaginable) on which the respondent is asked to 
indicate their current HRQOL state. 
The SF-12v2 consists of 12 Likert scale questions, covering 8 dimensions: general health, physical 
functioning, role-physical, bodily pain, vitality, social functioning, role-emotional and mental health. Both 
physical (PCS-12) and mental functioning (MCS-12) components can be assessed. The scores were 
standardized by a common scoring algorithm, ranging between 0 and 100, with lower scores 
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representing worse and higher scores representing better health(12). The SF-12v2 was not administered 
in Hungary. In Germany, the SF-36 was used instead of the SF-12v2(13).  
Statistical analyses 
All analyses were based on generalized linear mixed models in order to account for the clustering of 
patients within countries. The association between patient characteristics and HRQoL was initially 
adjusted for gender, age and educational level.  A further adjustment for age, gender, educational level, 
recruiting diagnosis, diabetes, history of stroke, recurring coronary events, smoking, physical activity and 
central obesity was applied. To investigate the relation between uncontrolled risk factors and HRQoL, in 
patients being medically treated, adjustment for gender, age, recruiting diagnosis, educational level, 
diabetes and history of stroke and recurring events was performed.   
Likewise the relation between the number of risk factors and HRQoL was investigated. In an additional 
analysis the number of risk factors was considered as a continuous variable, hence a linear regression 
analysis was performed. In both analyses adjustment for patient characteristics was applied. 
Significance levels were set at p<0.05. All statistical analyses were performed using the IBM SPSS 
statistical software (version 20.0). 
Results 
HRQoL data (full information on at least 1 HRQoL instrument) were available for 8734 patients (table 1). 
About three quarters (74.6%) of patients included in our analyses were male (n=6516). The average age 
of patients was 63.2 years (SD=9.5).  About 60% of patients included, had a cardiac revascularisation as 
recruiting diagnosis, 19.5% was diagnosed with AMI.  
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[insert Table 1 here] 
 
The overall mean PCS-12 and MCS-12 were 42.14 (SD=10.15) and 49.15 (SD=10.22) respectively. For the 
EQ-VAS a mean value of 66.42 (SD=18.84) was observed (table 2). 
Comparison of the HRQoL scores across countries indicated substantial differences, even after 
adjustment for age, gender and education (p<0.001) (figure 1). There was a tendency towards a poorer 
HRQoL in patients residing in Eastern European countries.  
 
[insert Figure 1 here] 
 
Likewise, gender, age and educational level were significantly associated with HRQoL, with men having a 
better self-perceived HRQoL compared to women, younger patients scoring higher on physical health 
and overall well-being, and those with lower education levels having worse HRQoL compared to those 
with higher levels of education (table 2 and 3). Furthermore, significantly lower HRQoL vales were found 
in patients with self-reported diabetes and higher values in those having undergone cardiac surgery or 
angioplasty, except for MCS-12, where no significant differences were found between diagnostic 
categories. In addition, cardiovascular history was also significantly associated with lower HRQoL 
measures, except for MCS-12, on which recurring events did not have any impact. Finally, better control 
of lifestyle parameters (central obesity, smoking, physical activity) was significantly associated with 
HRQoL (except for MCS-12 in central obesity). Based on the regression coefficients from table 3, these 
lifestyle parameters seem to be as important as cardiovascular history, gender or educational level.  
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[insert Table 2 here] 
 
[insert Table 3 here] 
 
Furthermore, HRQoL was significantly associated with certain cardiovascular risk factors in those patients 
being medically treated (table 4). Regarding blood pressure the associations with the different HRQoL 
measures were found to be non-significant or to go in the opposite direction, with worse HRQoL being 
associated with better blood pressure values.  Regarding total cholesterol a significant association was 
seen with MCS-12. No significant relation was found with LDL-cholesterol and fasting glucose, whereas 
HbA1c was significantly associated with all HRQoL measures in patients with diabetes. 
 
[insert Table 4  here] 
 
Looking at the number of CVD risk factors (blood pressure, total cholesterol, smoking, physical activity, 
central obesity) revealed that an increase in the amount of risk factors was associated with a gradual 
decrease in HRQoL even after adjustment for patient characteristics (table 5). Fitting a multiple linear 
model showed that each additional risk factor was associated with a 0.872 (p<0.001) decrease in PCS-12, 
a 0.326 (p=0.002) decrease in MCS-12 and a 1.368 (p<0.001) decrease on the EQ-VAS. 
 
[insert Table 5 here] 
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Discussion 
In this study, including 8734 stabilized CHD patients from 22 European countries, we aimed to analyse 
the association between HRQoL and patient characteristics. As expected the overall HRQoL scores in our 
cohort of CHD patients were lower compared to the general population(14) and similar to previously 
reported results(4). Furthermore, consistent with previous research and compared to the general 
population, having CHD seemed to have a limited influence on the mental health status, in contrast to 
the physical component and the overall health(4). 
Our analyses revealed that patient characteristics were significantly associated with HRQoL. Firstly, 
patients from Eastern European countries were more likely to have an impaired HRQoL. Similar findings 
have been previously reported in the general population with lower overall subjective well-being scores 
in less prosperous countries(15). Secondly, in accordance with the literature, CHD women reported 
lower HRQoL results than men(4;16-22), an observation which was also seen in the general 
population(4;23). With regard to age, a significant association - with younger patients reporting a better 
HRQoL - was observed with the PCS-12 and the EQ-VAS. Likewise other research groups found higher 
HRQoL values in younger CHD patients(17;21;22;24). Xie and colleagues reported similar results 
regarding the physical score, however for the mental score and the EQ-5D, better values were found in 
older CHD patients(4).  
Patients with self-reported diabetes were more likely to have a worse HRQoL. Similarly Xie et al. 
reported significantly lower HRQoL outcomes on both the SF-12 and the EQ-5D in these patients 
whereas Peterson et al. reported a 3 point lower score on PCS-12 in patients with diabetes(4;25). In 
addition, similar to the results reported by Lee et al., lower educated patients had significantly lower 
HRQoL outcomes(24). Analyses also revealed significantly higher HRQoL scores in patients undergoing 
revascularization as recruiting diagnosis, confirming previous studies(26-29). Other significant predictors 
12 
 
of impaired HRQoL were: having a history of stroke or suffering from a recurring coronary event. Several 
studies have shown a negative influence of stroke on HRQoL(4;30-33). Recurring cardiovascular events 
are also known to cause a decrease in HRQoL, although to a smaller extent than the HRQoL reduction 
associated with initial events(33).  
Lifestyle risk factors were significantly associated with HRQoL. In line with the literature, central obesity 
was associated with a decrease in HRQoL(24;34;35). In addition, we found an association between 
HRQoL and physical activity, with better HRQoL outcomes in physically active persons. Similarly, Sevinc 
et al. reported a higher HRQoL in coronary patients who are active or exercise regularly, compared to 
sedentary patients(28). Finally,  a significant association between HRQoL and current smoking was 
seen(36;37). In contrast to some authors stating that smoking cessation does not improve HRQoL 
significantly, we have found significantly higher HRQoL in quitters, similar to non-smokers (data not 
shown)(38-40). These results stress the importance of promoting healthy lifestyle changes in coronary 
patients, not only to prevent recurrent events but also to increase patients’ HRQoL. Our findings are in 
line with the latest European recommendations on CVD prevention, promoting multimodal, behavioral 
interventions in CHD patients(41). The interventions should include promotion of healthy lifestyle based 
on cognitive-behavioral strategies, through behavioral change including nutrition, exercise, smoking 
cessation, coping with the illness and improving medication adherence. 
When looking at the relation between HRQoL and CVD risk factors in patients being treated, less 
pronounced differences were seen across different risk groups. A negative association was found 
between SF-12v2 and raised blood pressure, which was eliminated after adjustment for medication 
intake. Indeed about 28% of the EUROASPIRE III patients was taking nitrates and 30% was taking 
diuretics at the time of the interview, medication which is often given in patients with angina and heart 
failure respectively, two conditions that are associated with a substantial decrease in HRQoL(21;42). 
Some previous studies did find a correlation between HRQoL and blood pressure, with worse HRQoL in 
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hypertensive patients whereas others did not find any association(28;42-44). An uncontrolled total 
cholesterol was significantly associated with a worse MCS-12, whereas no association was found with 
LDL-cholesterol. Similarly, Sevinç et al., found no significant association between HRQoL and 
cholesterol(28). HbA1c but not fasting glucose was significantly associated with HRQoL with worse health 
outcomes in those with a lower HRQoL. The latter observation was in accordance with published 
literature(24). Khanna et al. found a significant association between HbA1c and diabetes-specific HRQoL 
whereas Lau et al., only found an effect on the mental score of SF-12(45;46). Furtemore, in accordance 
with the literature, the number of risk factors was inversely associated with HRQoL(47). These results 
reaffirm the high importance of a holistic approach regarding risk factor prevention. 
Our analyses did not include the EQ-5Dindex since country-specific weights to calculate the EQ-5Dindex  
were not available for all 22 countries. However, when performing the analyses using the UK weights for 
all the countries, similar results as reported were found (data not shown). 
The EUROASPIRE III study is one of the largest surveys throughout Europe assessing patients’ subjective 
HRQoL in a stable coronary population. Data collection was organized in a standardized way and HRQoL 
was measured by means of 2 different widely used HRQoL instruments. In order to account for HRQoL 
differences inherent to the centre, multilevel analyses were used. The major limitation of our study is its 
cross-sectional design, therefore no statement about causality, only about the association between 
HRQoL and different characterstics, can be made. Furthermore, results should be interpreted with 
caution since most of the data were self-reported. Additionally, results are not country representative as 
the survey was carried out in selected geographical areas in each country. 
In conclusion, patient characteristics such as age, gender, educational level, physical activity, smoking 
status, central obesity and comorbidities seem to be significantly associated with HRQoL in coronary 
14 
 
patients. In addition HRQoL, especially the physical health components and the overall self-perceived 
well-being, seems to decrease significantly with an increasing number of risk factors. 
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Table 1: Patient characteristics at the time of the interview (n=8734) 
 Men (n=6516) Women (n=2218) All (n=8734) 
Age in years, Mean (SD) 
 
Age categories 
<50 years 
50-59 years 
60-69 years 
≥70 years 
 
62.3(9.5) 
 
 
10.6%(688/6516) 
29.5%(1924/6516) 
37.4%(2440/6516) 
22.5%(1464/6516) 
65.9(8.9) 
 
 
5.0%(112/2218) 
19.9%(442/2218) 
40.1%(890/2218) 
34.9%(774/2218) 
63.2(9.5) 
 
 
9.2%(800/8734) 
27.1%(2366/8734) 
38.1%(3330/8734) 
25.6%(2238/8734) 
Recruiting Diagnosis 
CABG 
PTCA 
AMI 
Ischaemia 
 
 
20.5%(1339/6516) 
43.1%(2806/6516) 
19.2%(1248/6516) 
17.2%(1123/6516) 
 
17.1%(379/2218) 
35.3%(782/2218) 
20.7%(459/2218) 
27.0%(598/2218) 
 
19.7%(1718/8734) 
41.1%(3588/8734) 
19.5%(1707/8734) 
19.7%(1721/8734) 
Education 
Primary education 
Secondary education 
High education 
 
 
22.5%(1456/6480) 
57.3%(3714/6480) 
20.2%(1310/6480) 
 
33.4%(737/2207) 
54.9%(1211/2207) 
11.7%(259/2207) 
 
25.2%(2193/8687) 
56.7%(4925/8687) 
18.1%(1569/8687) 
Diabetes 
Raised fasting glucose 
Raised HbA1c 
 
22.6%(1459/6454) 
90.7%(943/1040) 
60.9%(592/972) 
29.8%(657/2203) 
87.4%(396/453) 
73.8%(321/435) 
24.4%(2116/8657) 
89.7%(1339/1493) 
64.9%(913/1407) 
History of stroke 4.1%(268/6500) 5.7%(127/2212) 4.53%(395/8712) 
Recurrent CHD after recruiting diagnosis 
 
14.1%(912/6483) 11.4%(251/2204) 13.4%(1163/8687) 
Central obesity 
Current smoker  
Low physical activity 
 
Raised total cholesterol 
On lipid lowering medication (LLM) 
Raised total cholesterol in treated patients 
Raised LDL-cholesterol 
Raised  LDL-cholesterol in patients on LLM 
 
Raised Blood pressure  
On antihypertensive medication 
Raised Blood Pressure in medically 
patients 
45.7%(2940/6433) 
19.0%(1234/6500) 
63.9%(3880/6073) 
 
47.7%(2936/6155) 
80.3%(5210/6487) 
41.4%(2035/4912) 
52.6%(2511/4770) 
46.5%(1797/3865) 
 
54.5%(3544/6503) 
67.1%(4350/6481) 
61.4%(2665/4341) 
73.4%(1609/2193) 
10.9%(242/2214) 
72.8%(1483/2038) 
 
62.0%(1309/2111) 
77.9%(1718/2205) 
56.8%(929/1637) 
61.3%(980/1598) 
55.0%(697/1267) 
 
60.8%(1347/2215) 
80.3%(1778/2215) 
66.3%(1176/1775) 
52.7%(4549/8626) 
16.9%(1476/8714) 
66.1%(5363/8111) 
 
51.4%(4245/8266) 
79.7%(6928/8692) 
45.3%(2964/6549) 
54.8%(3491/6368) 
48.6%(2494/5132) 
 
56.1%(4891/8718) 
70.5%(6128/8696) 
62.8%(3841/6116) 
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Figure 1: Crude mean HRQoL outcomes across EUROASPIRE III countries 
 
 
* Adjusted for age, gender, educational level, recruiting diagnosis, diabetes, history of stroke and recurring events (p<0.001) 
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Table 2: Association between patient characteristics and different HRQoL instruments (Mean (SD)) 
 PCS-12  MCS-12  EQ-VAS  
All 42.14(10.15) 49.15(10.22) 66.42(18.84) 
    
Gender    
Male 43.20(10.02) 49.93(9.96) 67.85(18.59) 
Female 38.82(9.84) 46.75(10.64) 62.22(18.94) 
 p<0.001* p<0.001 p<0.001 
Age     
< 50 yrs 45.59(9.96)  48.84(10.51)  71.43(18.18)  
50-59 yrs  43.31(10.10)   48.94(10.22)   67.48(18.73)  
60-69 yrs  42.16(9.99)   49.57(10.19)   66.72(18.66)  
≥ 70 yrs    39.56(9.89)   48.90(10.13)  63.03(18.90) 
 p<0.001 p=0.034 p<0.001 
Recruiting diagnosis    
CABG 42.53(10.03)  50.23(9.88)  66.85(19.43)  
PTCA  43.03(10.06)   49.27(10.18)   67.92(18.50)  
AMI  41.83(10.13)   48.58(10.24)   65.64(18.56)  
ISCHAEMIA  40.04(10.18)  48.47(10.53)  63.63(18.88) 
 p<0.001 p=0.214 p=0.011 
Educational level    
Primary 40.95(10.36) 47.98(10.89) 64.87(20.00) 
Secondary 41.95(10.04) 49.27(10.08) 66.44(18.55) 
High 44.28(9.88) 50.44(9.53) 68.32(18.00) 
 p<0.001 p<0.001 p<0.001 
Diabetes     
No 42.94(9.97) 49.48(10.03) 67.34(18.57) 
Yes 39.46(10.27) 48.10(10.76) 63.50(19.43) 
 p<0.001 p<0.001 p<0.001 
Central Obesity    
No 43.53(9.98) 49.67(9.96) 68.33(18.45) 
Yes 40.87(10.11) 48.73(10.44) 64.76(18.99) 
 p<0.001 p=0.246 p<0.001 
Smoking    
No 42.04(10.14) 49.37(10.00) 66.56(18.71) 
Yes 42.64(10.17) 48.06(11.18) 65.71(19.40) 
 p=0.004 p<0.001 p<0.001 
Physical activity    
 <20min, 3x/week 40.79(10.19) 48.69(10.39) 64.39(19.12) 
≥20 min, 3x/week 45.52(9.28) 50.54(9.58) 71.08(17.22) 
 p<0.001 p<0.001 p<0.001 
History of stroke    
No 42.39(10.08) 49.24(10.16) 66.80(18.77) 
Yes 36.92(10.42) 47.17(11.30) 58.43(18.83) 
 p<0.001 p=0.001 p<0.001 
Recurring coronary event after IE    
No 42.34(10.13) 49.26(10.15) 66.76(18.85) 
Yes 40.90(10.19) 48.47(10.59) 64.25(18.64) 
 p<0.001 p=0.109 p<0.001 
*p-value adjusted for age, gender, educational level 
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Table 3: Results of multilevel linear regression analyses  for the association between patient characteristics and HRQOL 
 PCS-12 MCS-12 EQ-VAS 
PATIENT CHARACTERISTICS β  (SE)* p-value β  (SE)*  p-value β  (SE)*  p-value 
Intercept 56.709(1.033) <0.001 50.347(1.016) <0.001 84.60(1.88) <0.001 
Age -0.153(0.012) <0.001 0.011(0.013) 0.407 -0.183(0.023) <0.001 
Gender        
Male Reference  Reference  Reference  
Female -2.154(0.267) <0.001 -2.749(0.289) <0.001 -2.878(0.499) <0.001 
Educational level       
Primary education -0.971(0.293) 0.001 -0.570(0.315) 0.071 -2.046(0.549) <0.001 
Secondary education Reference  Reference   Reference  
High education 2.231(0.296) <0.001 1.144(0.320) <0.001 2.635(0.558) <0.001 
Recruiting diagnosis       
CABG 0.518(0.305) 0.090 0.604(0.329) 0.067 0.999(0.574) 0.082 
PTCA Reference   Reference  Reference  
AMI 0.115(0.315) 0.714 0.681(0.339) 0.045 1.677(0.606) 0.006 
Ischaemia -1.588(0.337) <0.001 0.282(0.363) 0.436 -0.210(0.629) 0.739 
Diabetes       
No Reference  Reference  Reference  
Yes -2.535(0.261) <0.001 -1.160(0.281) <0.001 -2.911(0.486) <0.001 
 History of stroke       
No Reference  Reference  Reference  
Yes -3.591(0.520) <0.001 -1.456(0.561) 0.009 -5.426(0.979) <0.001 
Recurrent coronary event after 
recruiting diagnosis 
      
No Reference  Reference  Reference  
Yes -1.688(0.319) <0.001 -0.580(0.344) 0.093 -2.251(0.604) <0.001 
Smoking       
No Reference  Reference  Reference  
Yes -0.917(0.301) 0.002 -1.622(0.325) <0.001 -2.062(0.570) <0.001 
Physical activity       
≥20 min, 3x/week Reference  Reference  Reference  
<20min, 3x/week -3.094(0.243) <0.001 -1.121(0.262) <0.001 -4.384(0.456) <0.001 
Central obesity       
No  Reference  Reference  Reference  
Yes -1.528(0.228) <0.001 0.042(0.246) 0.865 -1.887(0.432) <0.001 
*β (SE) = regression coefficient (standard error) 
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Table 4: Association between uncontrolled cardiovascular risk factors different HRQoL instruments (mean (SE)) 
 PCS-12  MCS-12  EQ-VAS  
Raised blood pressure in  treated 
patients 
   
No 38.24(0.80)* 47.04(0.73) 62.17(1.38) 
Yes 39.28(0.78) 47.65(0.71) 63.01(1.35) 
 p<0.001** p=0.040 p=0.099 
Raised total cholesterol in  treated 
patients 
   
No 39.35(0.79) 47.90(0.71) 63.84(1.42) 
Yes 39.11(0.79) 47.22(0.72) 62.96(1.43) 
 p=0.329 p=0.011 p=0.056 
Raised LDL-cholesterol in  treated 
patients 
   
No 39.40(0.84) 47.30(0.74) 63.08(1.50) 
Yes 39.43(0.84) 46.82(0.74) 62.65(1.50) 
 p=0.909 p=0.104 p=0.408 
Raised fasting glucose in diabetes 
patients 
   
No 37.75(1.33) 44.50(1.26) 58.43(2.34) 
Yes 37.58(1.10) 45.05(0.95) 58.83(1.84) 
 p=0.839 p=0.559 p=0.809 
Raised HbA1c in diabetes patients    
No 39.01(1.18) 47.43(1.17) 61.90(2.04) 
Yes 37.55(1.13) 45.62(1.10) 59.15(1.92) 
 p=0.013 p=0.006 p=0.013 
*adjusted mean 
**p-value adjusted for age, gender, educational level, recruiting diagnosis, diabetes, history of stroke and coronary 
recurring events 
 
 
Table 5: HRQoL means (SD) in relation to the number of risk factors 
Number of risk factors PCS-12 MCS-12 EQVAS 
0 
1 
2 
3 
4 
5 
p-value 
 
46.11(9.76) 
44.38(9.79) 
42.15(10.16) 
41.27(10.07) 
39.73(9.88) 
38.21(9.73) 
<0.001* 
50.80(9.22) 
50.01(9.62) 
49.49(10.16) 
48.62(10.33) 
47.98(10.76) 
46.85(12.37) 
0.023 
72.85(17.23) 
70.25(18.07) 
66.68(18.44) 
64.82(18.90) 
61.99(19.64) 
60.47(18.06) 
<0.001 
*p-value adjusted for age, gender, educational level, recruiting diagnosis, diabetes, history of stroke and 
recurring coronary events 
Risk factors included are: raised blood pressure, raised total cholesterol, current smoking, low physical activity 
and central obesity 
 
 
